Effective Management of XLA Associated Enteropathy with Vedolizumab Monotherapy

J Clin Immunol. 2024 Jun 19;44(7):150. doi: 10.1007/s10875-024-01747-0.

¹ Division of Allergy, Immunology, and Rheumatology, Department of Pediatrics, David Geffen School of Medicine, University of California, 10833 Le Conte MDCC 12-430, Los Angeles, CA, 90095, USA.
² Division of Digestive Diseases, Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, CA, 90095, USA.
³ Division of Infectious Diseases, Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, CA, 90095, USA.
⁴ Division of Allergy, Immunology, and Rheumatology, Department of Pediatrics, David Geffen School of Medicine, University of California, 10833 Le Conte MDCC 12-430, Los Angeles, CA, 90095, USA. [email protected].

No abstract available

Publication types